Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer
Clinical trial NCT04857619 · COMPLETED
Trial details
- NCT number
- NCT04857619
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-14
- Primary completion
- 2022-10-31
- Enrollment
- 763
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.